We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+24.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.8B
AUM Growth
+$442M
Cap. Flow
+$225M
Cap. Flow %
1.62%
Top 10 Hldgs %
20.13%
Holding
998
New
320
Increased
181
Reduced
201
Closed
285

Top Sells

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$134M
2
NFLX icon
Netflix
NFLX
+$107M
3
PG icon
Procter & Gamble
PG
+$106M
4
MMM icon
3M
MMM
+$102M
5
ZBH icon
Zimmer Biomet
ZBH
+$91.2M

Sector Composition

Rank Sector Weight
1 Industrials 15.04%
2 Financials 14.57%
3 Technology 12.47%
4 Healthcare 12.2%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YELP icon
501
Yelp
YELP
$1.38B
$756K 0.01%
24,880
-6,302
-20% -$194K
BBWI icon
502
Bath & Body Works
BBWI
$4.01B
$756K 0.01%
37,644
+6,036
+19% +$133K
AMPH icon
503
Amphastar Pharmaceuticals
AMPH
$825M
$739K 0.01%
+27,593
New +$711K
EMN icon
504
Eastman Chemical
EMN
$7.8B
$736K 0.01%
11,523
-14,323
-55% -$883K
KAI icon
505
Kadant
KAI
$3.69B
$732K 0.01%
+2,567
New +$729K
BBT
506
Beacon Financial Corp
BBT
$2.53B
$728K 0.01%
27,612
+2,031
+8% +$51.4K
CALX icon
507
Calix
CALX
$2.3B
$728K 0.01%
+13,753
New +$801K
EFC
508
Ellington Financial
EFC
$1.68B
$726K 0.01%
53,450
-29,106
-35% -$396K
DIS icon
509
Walt Disney
DIS
$165B
$724K 0.01%
6,362
+3,781
+146% +$416K
METC icon
510
Ramaco Resources Class A
METC
$676M
$722K 0.01%
40,097
+30,717
+327% +$807K
CPRX
511
DELISTED
Catalyst Pharmaceutical
CPRX
$722K 0.01%
30,914
-29,823
-49% -$664K
DLB icon
512
Dolby
DLB
$4.72B
$718K 0.01%
+11,179
New +$751K
ST icon
513
Sensata Technologies
ST
$6.65B
$716K 0.01%
21,496
+11,068
+106% +$354K
PRKS icon
514
United Parks & Resorts
PRKS
$2.11B
$707K 0.01%
+19,468
New +$809K
INOD icon
515
Innodata
INOD
$1.83B
$706K 0.01%
+13,859
New +$904K
POOL icon
516
Pool Corp
POOL
$6.7B
$705K 0.01%
3,082
-42,813
-93% -$11.1M
WST icon
517
West Pharmaceutical
WST
$23.1B
$695K 0.01%
2,526
-163,816
-98% -$44.8M
UTHR icon
518
United Therapeutics
UTHR
$26.3B
$693K 0.01%
+1,423
New +$663K
HST icon
519
Host Hotels & Resorts
HST
$16.8B
$678K ﹤0.01%
38,235
-3,428
-8% -$59.2K
ACHR icon
520
Archer Aviation
ACHR
$3.64B
$677K ﹤0.01%
+89,969
New +$847K
ENTG icon
521
Entegris
ENTG
$19.7B
$676K ﹤0.01%
+8,028
New +$697K
ACIW icon
522
ACI Worldwide
ACIW
$5.72B
$675K ﹤0.01%
14,123
-5,326
-27% -$258K
AIT icon
523
Applied Industrial Technologies
AIT
$12.8B
$672K ﹤0.01%
+2,618
New +$670K
JBI icon
524
Janus International
JBI
$722M
$670K ﹤0.01%
+102,392
New +$798K
BDC icon
525
Belden
BDC
$4B
$667K ﹤0.01%
5,722
-370
-6% -$43.2K

Similar funds

Freestone Grove Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Freestone Grove Partners held 998 positions worth $13.8B, up 3.3% from $13.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Freestone Grove Partners's Q4 2025 filing shows 320 new, 181 increased, 201 reduced and 285 closed positions. Its largest new stake was Amazon: 683,670 shares worth $158M. The largest sale was Cintas, an estimated $134M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 17% a quarter earlier, followed by Financials and Technology.

  • Freestone Grove Partners's largest Q4 2025 buy was Amazon: 683,670 shares worth $158M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $767M increase.
  • Freestone Grove Partners's biggest Q4 2025 reduction was Cintas, cutting an estimated $134M.
  • Freestone Grove Partners fully exited Netflix in Q4 2025, selling an estimated $107M.
  • Freestone Grove Partners's ten largest holdings make up 20% of its $13.8B portfolio in Q4 2025.
  • Freestone Grove Partners opened 320 new positions and closed 285 in Q4 2025.
  • Freestone Grove Partners's portfolio value rose 3.3% quarter-over-quarter to $13.8B.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.